FERMT1 promotes gastric cancer progression by activating the NF-κB pathway and predicts poor prognosis

References

• Jung KW, Won YJ, Hong S, Kong HJ, Lee ES. Prediction of Cancer Incidence and Mortality in Korea, 2020[J]. Cancer Res Treat. 2020;52(2):351–358.
   Google Scholar
• Agnes A, Biondi A, Laurino A, Persiani R, D’Ugo D. Global updates in the treatment of gastric cancer: a systematic review. Part 1: staging, classification and surgical treatment[J]. Updates Surg. 2020;72(2):341–353.
   Web of Science ®Google Scholar
• Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016[J]. CA Cancer J Clin. 2016;66(4):271–289.
   PubMed Web of Science ®Google Scholar
• Strong VE. Progress in gastric cancer[J]. Updates Surg. 2018;70(2):157–159.
   PubMed Web of Science ®Google Scholar
• Valinotto LE, Natale MI, Lusso SB, Cella E, Gutiérrez O, Sebastiani F, Manzur GB. A novel pathogenic FERMT1 variant in four families with Kindler syndrome in Argentina[J]. Pediatr Dermatol. 2020;37(2):337–341.
   PubMed Web of Science ®Google Scholar
• Yan Q, Chen T, Yang H, Yu H, Zheng Y, He T, Wang J. The Effect of FERMT1 Regulated by miR-24 on the Growth and Radiation Resistance of Esophageal Cancer[J]. J Biomed Nanotechnol. 2019;15(3):621–631.
   PubMed Web of Science ®Google Scholar
• Mas-Vidal A, Miñones-Suárez L, Toral JF, Mallo S, Pérez-Oliva N. A novel mutation in the FERMT1 gene in a Spanish family with Kindler’s syndrome[J]. J Eur Acad Dermatol Venereol. 2010;24(8):978–979.
   PubMed Web of Science ®Google Scholar
• Chmel N, Danescu S, Gruler A, Kiritsi D, Bruckner-Tuderman L, Kreuter A, Kohlhase J, Has C. A deep-intronic FERMT1 mutation causes kindler syndrome: an explanation for genetically unsolved cases[J]. J Invest Dermatol. 2015;135(11):2876–2879.
   PubMed Web of Science ®Google Scholar
• Has C, Castiglia D, Del Rio M, Diez MG, Piccinni E, Kiritsi D, Kohlhase J, Itin P, Martin L, Fischer J, et al. 2011. Kindler syndrome: extension of FERMT1 mutational spectrum and natural history[J]. Hum Mutat. 32(11):1204–1212.
   PubMed Web of Science ®Google Scholar
• Jobard F, Bouadjar B, Caux F, Hadj-Rabia S, Has C, Matsuda F, Weissenbach J, Lathrop M, Prud’homme JF, Fischer J. Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome[J]. Hum Mol Genet. 2003;12(8):925–935.
   PubMed Web of Science ®Google Scholar
• Youssefian L, Vahidnezhad H, Barzegar M, Li Q, Sotoudeh S, Yazdanfar A, Ehsani AH, Kajbafzadeh AM, Mozafari N, Ebrahimi Daryani N, et al. 2015. The Kindler syndrome: a spectrum of FERMT1 mutations in Iranian families[J]. J Invest Dermatol. 135(5):1447–1450.
   PubMed Web of Science ®Google Scholar
• Zhou C, Song S, Zhang J. A novel 3017-bp deletion mutation in the FERMT1 (KIND1) gene in a Chinese family with Kindler syndrome[J]. Br J Dermatol. 2009;160(5):1119–1122.
   PubMed Web of Science ®Google Scholar
• Ussar S, Wang HV, Linder S, Fässler R, Moser M. The kindlins: subcellular localization and expression during murine development[J]. Exp Cell Res Exp Cell Res. 2006;312(16):3142–3151.
   PubMed Web of Science ®Google Scholar
• Rognoni E, Ruppert R, Fässler R. The kindlin family: functions, signaling properties and implications for human disease[J]. J Cell Sci. 2016;129(1):17–27.
   PubMed Web of Science ®Google Scholar
• Liu CC, Cai DL, Sun F, Wu ZH, Yue B, Zhao SL, Wu XS, Zhang M, Zhu XW, Peng ZH, et al. 2017. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of beta-catenin transcriptional activity[J]. Oncogene. 36(13):1779–1792.
   PubMed Web of Science ®Google Scholar
• Fan J, Yan D, Teng M, Tang H, Zhou C, Wang X, Li D, Qiu G, Peng Z. Digital transcript profile analysis with aRNA-LongSAGE validates FERMT1 as a potential novel prognostic marker for colon cancer[J]. Clin Cancer Res. 2011;17(9):2908–2918.
   PubMed Web of Science ®Google Scholar
• Sin S, Bonin F, Petit V, Meseure D, Lallemand F, Bièche I, Bellahcène A, Castronovo V, de Wever O, Gespach C, et al. 2011. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis[J]. J Natl Cancer Inst. 103(17):1323–1337.
   PubMedGoogle Scholar
• Rognoni E, Widmaier M, Jakobson M, Ruppert R, Ussar S, Katsougkri D, Böttcher RT, Lai-Cheong JE, Rifkin DB, McGrath JA, et al. 2014. Kindlin-1 controls Wnt and TGF-beta availability to regulate cutaneous stem cell proliferation[J]. Nat Med. 20(4):350–359.
   PubMed Web of Science ®Google Scholar
• Weinstein EJ, Bourner M, Head R, Zakeri H, Bauer C, Mazzarella R. URP1: a member of a novel family of PH and FERM domain-containing membrane-associated proteins is significantly over-expressed in lung and colon carcinomas[J]. Biochim Biophys Acta. 2003;1637(3):207–216.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhang J, Xu S, Jia C, Meng W, Tang H, Zhang X, Zhang Y, Fu B. Knockdown of PHF5A Inhibits Migration and Invasion of HCC Cells via Downregulating NF-kB Signaling[J]. Biomed Res Int. 2019;2019:1621854.
   PubMed Web of Science ®Google Scholar
• Yang H, Cho ME, Li TW, Peng H, Ko KS, Mato JM, Lu SC. MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma[J]. J Clin Invest. 2013;123(1):285–298.
   PubMed Web of Science ®Google Scholar
• Yang H, Cho ME, Li TW, Peng H, Ko KS, Mato JM, Lu SC. LincRNA-Gm4419 knockdown ameliorates NF-kappaB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy[J]. Cell Death Dis. 2017;8(2):e2583.
   PubMedGoogle Scholar
• Zhu S, Deng S, He C, Liu M, Chen H, Zeng Z, Zhong J, Ye Z, Deng S, Wu H, et al. 2018. Reciprocal loop of hypoxia-inducible factor-1alpha (HIF-1alpha) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription[J]. J Pathol. 245(3):349–360.
   PubMed Web of Science ®Google Scholar
• Zhao L, Guo H, Zhou B, Feng J, Li Y, Han T, Liu L, Li L, Zhang S, Liu Y, et al. 2016. Long non-coding RNA SNHG5 suppresses gastric cancer progression by trapping MTA2 in the cytosol[J]. Oncogene. 35(44):5770–5780.
   PubMed Web of Science ®Google Scholar
• Liu JY, Jiang L, Liu JJ, He T, Cui YH, Qian F, Yu PW. AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients[J]. Sci Rep. 2018;8(1):11955.
   PubMedGoogle Scholar
• Wang Y, Zhou BP. Epithelial-mesenchymal transition in breast cancer progression and metastasis[J]. Chin J Cancer. 2011;30(9):603–611.
   PubMedGoogle Scholar
• Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression[J]. J Clin Invest. 2004;114(4):569–581.
   PubMed Web of Science ®Google Scholar
• Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function[J]. Nat Rev Mol Cell Biol. 2007;8(1):49–62.
   PubMed Web of Science ®Google Scholar
• KINDLER T. Congenital poikiloderma with traumatic bulla formation and progressive cutaneous atrophy[J]. Br J Dermatol. 1954;66(3):104–111.
   PubMed Web of Science ®Google Scholar
• Siegel DH, Ashton GH, Penagos HG, Lee JV, Feiler HS, Wilhelmsen KC, South AP, Smith FJ, Prescott AR, Wessagowit V, et al. 2003. Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome[J]. Am J Hum Genet. 73(1):174–187.
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol. 2014;15:178–196.
   PubMed Web of Science ®Google Scholar
• Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition[J]. Sci Signal. 2014;7:e8.
   Web of Science ®Google Scholar
• Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression[J]. Nat Rev Immunol. 2005;5(10):749–759.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Karin M. NF-kappaB, inflammation, immunity and cancer: coming of age[J]. Nat Rev Immunol. 2018;18(5):309–324.
   PubMed Web of Science ®Google Scholar
• Radisky DC, Bissell MJ. NF-kappaB links oestrogen receptor signalling and EMT[J]. Nat Cell Biol. 2007;9(4):361–363.
   PubMed Web of Science ®Google Scholar
• Puisieux A, Brabletz T, Caramel J. Oncogenic roles of EMT-inducing transcription factors[J]. Nat Cell Biol. 2014;16(6):488–494.
   PubMed Web of Science ®Google Scholar
• Ren D, Yang Q, Dai Y, Guo W, Du H, Song L, Peng X. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-kappaB signaling pathway[J]. Mol Cancer. 2017;16(1):117.
   PubMed Web of Science ®Google Scholar
• Shyamsunder P, Verma RS, Lyakhovich A. ROMO1 regulates RedOx states and serves as an inducer of NF-kB-driven EMT factors in Fanconi anemia[J]. Cancer Lett. 2015;361(1):33–38.
   PubMed Web of Science ®Google Scholar
• Basak S, Shih VF, Hoffmann A. Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system[J]. Mol Cell Biol. 2008;28(10):3139–3150.
   PubMed Web of Science ®Google Scholar
• Perkins ND. The diverse and complex roles of NF-kappaB subunits in cancer[J]. Nat Rev Cancer. 2012;12(2):121–132.
   PubMed Web of Science ®Google Scholar